In AD-like rats, emodin was observed to reduce microglial activation and improve cognitive function and cerebral microvascular integrity by decreasing levels of 5-lipoxygenase (5-LO), IL-6, and TNF-α [46]. Here, IL6 is linked to Alzheimer disease.